(NP (NP (JJ Molecular) (NN basis)) (PP (IN of) (NP (NP (DT a) (JJ multiple) (NN lymphokine) (NN deficiency)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ severe) (JJ combined) (NN immunodeficiency))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN reported) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN T) (NNS lymphocytes)) (PP (IN of) (NP (NP (DT a) (NN child)) (PP (IN with) (NP (JJ severe) (JJ combined) (NN immunodeficiency)))))) (VP (VBP are) (ADJP-PRD (JJ defective)) (PP (IN in) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (JJ several) (NN lymphokine) (NNS genes)) (SBAR (WHNP-27 (WDT that)) (S (NP-SBJ (-NONE- *T*-27)) (VP (VBP include) (NP (NP-COOD (NP (NN IL2)) (, ,) (NP (NN IL3)) (, ,) (NP (NN IL4)) (, ,) (CC and) (NP (NN IL5))) (, ,) (SBAR (WHNP-28 (WDT which)) (S (NP-SBJ (-NONE- *T*-28)) (VP (VBP encode) (NP (NP (NNS interleukins) (NP-COOD (NP (CD 2)) (, ,) (NP (CD 3)) (, ,) (NP (CD 4)) (, ,) (CC and) (NP (CD 5)))) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN IL-2)) (, ,) (NP (CD -3)) (, ,) (NP (CD -4)) (, ,) (CC and) (NP (CD -5))) (-RRB- -RRB-))))))))))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-29)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NP (DT the) (NN defect)) (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN T) (NNS lymphocytes)))) (VP (VBD involved) (NP (NP (DT a) (JJ trans-acting) (NN factor)) (ADJP (JJ common) (PP (TO to) (NP (DT the) (VBN affected) (NN lymphokine) (NNS genes))))))))))) (, ,) (NP-SBJ-29 (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NN ability) (S (-NONE- *ICH*-30))) (PP (IN of) (NP (NP (JJ nuclear) (NNS factors)) (PP (IN from) (NP (NP (DT the) (NN patient) (POS 's)) (NN T) (NNS lymphocytes))))) (S-30 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB bind) (NP (NP (NN response) (NNS elements)) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (JJ regulatory) (NN region)) (PP (IN of) (NP (NN IL2)))))))))))) (. .))
(S (NP-SBJ-COOD (NP (JJ Nuclear) (NN factor) (NN NF-kB)) (, ,) (NP (NP (NN activation) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (, ,) (NP (NN OCT-1)) (, ,) (CC and) (NP (NN NF-IL-2B) (NN binding) (NN activity))) (VP (VBD were) (ADJP-PRD (JJ normal))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-)))) (PP-COOD (PP (TO to) (NP (NP (PRP$ its) (NN response) (NN element)) (PP (IN in) (NP (DT the) (NN IL2) (NN enhancer))))) (CC and) (PP (TO to) (NP (NP (DT an) (JJ NF-AT-like) (NN response) (NN element)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (NN IL4) (NN enhancer)))))))) (VP (VBD was) (ADJP-PRD (JJ abnormal))) (. .))
(S (S (NP-SBJ (-NONE- *-31)) (VP (TO To) (VP (VB ascertain) (SBAR (IN whether) (S (NP-SBJ (DT the) (JJ abnormal) (NN NF-AT) (NN binding) (NN activity)) (VP (VBD was) (ADJP-PRD (JJ related) (PP (TO to) (NP (DT an) (JJ impaired) (NN function)))))))))) (, ,) (NP-SBJ-31 (PRP we)) (VP (VBD transfected) (NP (NP-COOD (NP (NN patient)) (CC and) (NP (NN control))) (NN T) (NNS lymphocytes)) (PP (IN with) (NP (NP (NNS constructs)) (VP (VBG containing) (NP (NP (DT the) (NN reporter) (NN gene)) (VP (JJ encoding) (NP (NP (NP (NN chloramphenicol) (NN acetyl) (NN transferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP-COOD (PP (IN of) (NP (DT the) (JJ entire) (NN IL2) (JJ regulatory) (NN region))) (CC or) (PP (IN of) (NP (NP (NNS multimers)) (PP (IN of) (NP (JJ individual) (NN enhancer) (NNS sequences))))))))))))))) (. .))
(S (NP-SBJ (NP (NN CAT) (NN expression)) (VP (VBN directed) (NP (-NONE- *)) (PP-COOD (PP (IN by) (NP-LGS (DT the) (NN IL2) (JJ regulatory) (NN region))) (CC or) (PP (IN by) (NP-LGS (NP (DT a) (NN multimer)) (PP (IN of) (NP (DT the) (JJ NF-AT-binding) (NN site)))))))) (VP (VBD was) (ADJP-PRD (RB markedly) (JJR lower)) (PP (IN in) (NP (DT the) (NN patient))) (PP (JJ relative) (TO to) (NP (NNS controls)))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN CAT) (NN gene) (NN expression)) (VP (VBN directed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN multimer)) (PP (IN of) (NP (DT the) (ADJP (NN OCT-1) (NN proximal) (-LRB- -LRB-) (NN OCT-1p) (-RRB- -RRB-) (JJ -binding)) (NN site))))))) (VP (VBD was) (ADJP-PRD (JJ equivalent)) (PP (IN in) (NP-COOD (NP (NN patient)) (CC and) (NP (NNS controls))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (DT an) (NN abnormality)) (UCP (UCP-COOD (PP (IN of) (NP (-NONE- *RNR*-32))) (CC /) (VP (CC or) (NP (-NONE- *RNR*-32)))) (NP-32 (JJ influencing)))) (VP (NN NF-AT) (VP (MD may) (NP (NP (VB underlie) (DT the) (JJ multiple) (NN lymphokine)) (PP (NN deficiency) (NP (IN in) (DT this))))))))) (NN patient))
